"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT02568800","Prolonged Infusion Cefepime and Nosocomial Infections","PICNIC","Unknown status","No Results Available","Urinary Tract Infection|Respiratory Tract Infection","Drug: Prolonged Cefepime Infusion|Drug: Usual Cefepime Infusion","Death|Duration of hospital stay|Intensive care unit (ICU) admission|Duration of intensive care unit (ICU) stay|Treatment change|Treatment success|Time to clinical stability","Hospital de Clinicas de Porto Alegre","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 3","134","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","15-0392","October 2015","March 2016","September 2016","October 6, 2015","null","October 16, 2015","Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil","","https://ClinicalTrials.gov/show/NCT02568800"
2,"NCT01768182","Folinic Acid and Vascular Reactivity in HIV",,"Completed","No Results Available","Human Immunodeficiency Virus (HIV) Infection","Dietary Supplement: Folinic Acid|Other: Placebo","Change in vascular reactivity|Change in Laboratory measurements","Hospital de Clinicas de Porto Alegre|Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","08035","August 2009","September 2011","September 2011","January 15, 2013","null","January 25, 2013","Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil","","https://ClinicalTrials.gov/show/NCT01768182"
3,"NCT01837277","Impact of a Raltegravir-based Regimen on Early Mortality of Severely Immunocompromised AIDS Patients",,"Unknown status","No Results Available","Severely Immunocompromised HIV Patients","Drug: Use of Raltegravir-based regimens|Drug: Efavirenz-based regimens","early mortality|Viral load|CD4 count","Fundação Bahiana de Infectologia","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2|Phase 3","92","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","SevereHIV","March 2015","March 2016","March 2016","April 23, 2013","null","March 6, 2015","Fundação Bahiana de Infectologia/SEI, Salvador, Bahia, Brazil|Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil|Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil","","https://ClinicalTrials.gov/show/NCT01837277"
